The global market for monkeypox vaccines and treatments is anticipated to expand at a compound annual growth rate (CAGR) of 11% during the forecast period of 2023 to 2031. The market is anticipated to be driven by factors such as the increasing incidence of monkeypox infection across the globe and the rising demand for treatment and prevention methods. Bavarian Nordic A/S, for example, announced in July 2022 that it had received an additional order for 2.5 million doses of JYNNEOS from the U.S. BARDA. In addition, a surge in product approvals and expanding government initiatives to fund research related to monkeypox infection are anticipated to drive market expansion. According to the CDC, as of September 8, 2022, 56,609 cases and 18 deaths had been reported worldwide. The United States and Europe have the most reported cases. Increasing incidence rates in these regions encourage market participants to develop novel treatments to alleviate the disease burden in their respective regions. To increase their market share, key players are adopting strategies such as new product development, mergers acquisitions, and partnerships. Japan, for example, approved the LC16 KMB vaccine for monkeypox disease in August 2022. Key players in the market include SIGA Technologies, Inc., Chimerix, Inc., Bavarian Nordic, Sanofi SA, Emcure Pharma, and Jinan Jinda Pharmaceutical Chemistry Co., Ltd.
In addition, government initiatives such as the U.S. Monkeypox Research Priorities, which aim to boost RD and raise public awareness of monkeypox, are anticipated to boost growth. In addition, the United States government and its international partners are intensifying their efforts to advance monkeypox research. Infection-related research activities supported by the government include, among others, clinical and epidemiologic observational modeling and vaccine and therapeutic clinical trials. Such initiatives are anticipated to exponentially increase the demand for vaccinations in the coming years.
Ongoing regulatory approvals and EUAs contribute to market growth. For instance, in August 2022, the U.S. FDA approved emergency use authorization for the intradermal injectable JYNNEOS vaccine for healthcare professionals 18 years and older who were determined to be at a higher risk of monkeypox infection. This approval permits two intradermal injections of JYNNEOS four weeks apart.
In addition, the EMA's human medicines committee recommended in July 2022 that the indication for the smallpox vaccine IMVANEX be extended to include protection against monkeypox infection. Since its approval in 2013, IMVANEX has been regarded as a useful vaccine due to the similarities between smallpox and monkeypox. In addition, increasing R&D expenditures and the use of the smallpox vaccine as an off-label product for vaccination against monkeypox are anticipated to drive the global market.
The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends, and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
This product will be delivered within 2 business days.
Increase In the Incidence of Monkeypox Disease to Fuel the Growth
The rising incidence of monkeypox is anticipated to increase the demand for new drugs and vaccines to treat this disease. This is anticipated to drive the growth of the global monkeypox treatment market over the forecast period. According to data published by the Centers for Disease Control and Prevention, there are 31,800 confirmed cases of monkeypox worldwide as of August 9, 2022, of which 31,425 are in countries that have never previously reported monkeypox. While 375 in countries where monkeypox has historically been reported. In addition, according to a study published in the New England Journal of Medicine, between April and June 2022, 98% of monkeypox infections in 16 countries around the world occurred in men who have sex with other men and in LGBT communities. During the forecast period, the market is projected to expand at a rate that is proportional to the incidence of infection and demand for immunization. As of 8 September 2022, the world had reported 56,609 new cases of monkeypox infection, and the number is rising. In addition, according to CDC data, as of September 6, 2022, the U.S. had administered 461 049 vaccine doses in the country.Increasing Demand for Vaccines and New Treatments for Monkeypox
On August 4, 2022, the United States Department of Health and Human Services declared the outbreak of monkeypox a public health emergency. Due to this, the demand for vaccines and improved treatments for monkeypox has increased. In addition, according to the Centres for Disease Control and Prevention, the demand for the vaccine exceeds the vaccine supply in the United States. Consequently, the enormous demand for vaccines and treatments for monkeypox is anticipated to propel the global monkeypox treatment market.Government Initiatives to Promote Market Growth
In addition, various government initiatives for the supply, distribution, and availability of anti-infective vaccines are expected to foster market expansion in the coming years. For example, the Department of Health and Human Services announced in July 2022 that it would increase the availability of vaccines by acquiring an additional 144,000 doses of the JYNNEOS vaccine for the treatment of monkeypox infection. In addition, the Health Resources and Services Administration allocated funds to expedite the distribution of JYNNEOS to the Ryan White HIV/AIDS Program (RWHAP) to increase the vaccination rate among the high-risk population.In addition, government initiatives such as the U.S. Monkeypox Research Priorities, which aim to boost RD and raise public awareness of monkeypox, are anticipated to boost growth. In addition, the United States government and its international partners are intensifying their efforts to advance monkeypox research. Infection-related research activities supported by the government include, among others, clinical and epidemiologic observational modeling and vaccine and therapeutic clinical trials. Such initiatives are anticipated to exponentially increase the demand for vaccinations in the coming years.
Active Role of FDA Motivating the Market Growth
In addition, the U.S. FDA announced in September 2022 additional measures to increase testing capacity and accessibility in response to the current outbreak. Under this initiative, the FDA is anticipated to recommend EUA requests for diagnostic tests for monkeypox and to promote diagnosis. Consequently, such initiatives are anticipated to drive market growth during the forecast period.Ongoing regulatory approvals and EUAs contribute to market growth. For instance, in August 2022, the U.S. FDA approved emergency use authorization for the intradermal injectable JYNNEOS vaccine for healthcare professionals 18 years and older who were determined to be at a higher risk of monkeypox infection. This approval permits two intradermal injections of JYNNEOS four weeks apart.
In addition, the EMA's human medicines committee recommended in July 2022 that the indication for the smallpox vaccine IMVANEX be extended to include protection against monkeypox infection. Since its approval in 2013, IMVANEX has been regarded as a useful vaccine due to the similarities between smallpox and monkeypox. In addition, increasing R&D expenditures and the use of the smallpox vaccine as an off-label product for vaccination against monkeypox are anticipated to drive the global market.
Increasing the Vaccine's Adverse Reactions to Limit the Market Expansion
The major restraint for the global monkeypox treatment market is the increasing side effects associated with the drugs used to treat this disease; consequently, this can hinder the market's growth. Major side effects of drugs used to treat monkeypox include mild stomach upset, dry mouth, diminished concentration, and depression.Drugs Dominate the Market by Products
In 2021, the drugs segment led the market with a share of more than 70.0%. The growth is being fuelled by several factors, including an increase in the number of patients with monkeypox, the increased use of antiviral drugs, and the high cost of symptomatic treatment. The U.K. approved SIGA's tecovirimat (oral) in July 2022 for the treatment of monkeypox and other indications in adults and children with body weights exceeding 13 kg. The drug is also approved for the treatment of monkeypox in other European nations. Vaccines are anticipated to grow at a substantial rate over the forecast period. Increasing adoption of vaccines for monkeypox infection, rising vaccination awareness, and extensive R&D efforts to develop novel products are anticipated to contribute to the segment's growth. In addition, various government initiatives to make vaccines accessible are anticipated to stimulate segment expansion. In August 2022, for example, the HHS facilitated an agreement between Grand River Aseptic Manufacturing and Bavarian Nordic to establish the first U.S. finish and fill line for the JYNNEOS vaccine.Male Remained the Dominant End Users
In 2021, the male segment dominated the market with a revenue share of more than 90 percent. The greater prevalence of monkeypox in men compared to women is the primary factor driving demand for this segment. According to the CDC, the virus affected approximately 13,826 males. Therefore, the higher prevalence of infection in men compared to women is likely to contribute to segment expansion. In addition, a greater number of vaccine doses administered to men has increased the segment share. Until September 6, 2022, more than 90 percent of total JYNNEOS vaccine doses are administered to males in the United States.Hospitals Remain as the Key End Users Contributing over 75% of Market Revenues
In 2021, hospitals commanded a revenue share of over 75.0%, a position they are projected to maintain throughout the forecast period. As a result of the outbreak of monkeypox, hospitalizations are expected to increase, as will the demand for therapeutic products in hospitals for symptomatic treatment. In addition, government organizations such as the American Hospital Association and the Department of Health and Human Services are implementing initiatives to improve the treatment and continuous monitoring of patients with monkeypox infections, which is increasing the hospital's patient population. The specialty clinics segment is anticipated to experience the highest growth rate during the forecast period. The expansion of this market segment is influenced by rising immunization awareness and high infection rates.Oral Segment Dominated the Market by Administration Mode
In 2021, the oral segment held over 65.0% of the market share. Among the factors contributing to the expansion of the segment are the increased demand for oral route therapeutics, the ease of administration, and the cost-effectiveness of oral products. In addition, the majority of common medications, such as tecovirimat and brincidofovir, are administered orally. During the forecast period, the injectable segment is expected to grow at a double-digit rate. Increasing demand for vaccines, greater bioavailability of injectable products, rapid onset of action of treatment products, and decreased likelihood of first-pass metabolism in intravenous products are among the factors contributing to the segment's expansion. In addition, the injectable route helps to optimize the vaccine's immunogenicity and reduce adverse reactions at the injection site. JYNNEOS is an example of an injectable vaccine that is administered subcutaneously in two doses (0.5 mL) four weeks apart.North America Remains as the Global Leader
In 2021, North America dominated the market with a revenue share of over 40.0% due to the presence of a large number of leading players and the diverse strategic initiatives they had undertaken. In addition, an increase in disease prevalence and a rise in public vaccination awareness are anticipated to stimulate regional market growth. In addition, government support and increased R&D expenditures are anticipated to generate lucrative growth opportunities for the North American region. Asia-Pacific is anticipated to experience the most rapid expansion over the forecast period. The rising incidence of monkeypox infections and the increase in research and development for the development of preventative and therapeutic options are among the primary factors driving the market. Increasing infection rates in Asia Pacific nations such as Australia, Singapore, and India are anticipated to fuel market expansion.Historical Forecast Period
This study report represents analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2023 to 2031.The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends, and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
Research Methodology
The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. A key data point that enables the estimation of Monkeypox Vaccines And Treatments market are as follows:- Research and development budgets of manufacturers and government spending
- Revenues of key companies in the market segment
- Number of end users and consumption volume, price and value.
- Geographical revenues generate by countries considered in the report
- Micro and macro environment factors that are currently influencing the Monkeypox Vaccines And Treatments market and their expected impact during the forecast period.
Market Segmentation
Product
- Vaccine
- JYNNEOS/ Imvanex
- Smallpox Vaccine
- Others
- Drugs
- Tecovirimat
- Brincidofovir
- Cidofovir
- Others
- Vaccinia Immune Globulin (VIG)
Gender
- Male
- Female
- Others
Route of Administration
- Oral
- Injectable
End-use
- Hospitals
- Specialty Clinics
- Others
Key questions answered in this report
- What are the key micro and macro environmental factors that are impacting the growth of Monkeypox Vaccines And Treatments market?
- What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
- Estimated forecast and market projections up to 2031.
- Which segment accounts for the fastest CAGR during the forecast period?
- Which market segment holds a larger market share and why?
- Are low and middle-income economies investing in the Monkeypox Vaccines And Treatments market?
- Which is the largest regional market for Monkeypox Vaccines And Treatments market?
- What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East Africa?
- Which are the key trends driving Monkeypox Vaccines And Treatments market growth?
- Who are the key competitors and what are their key strategies to enhance their market presence in the Monkeypox Vaccines And Treatments market worldwide?
This product will be delivered within 2 business days.
Table of Contents
1. Preface1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted
2. Executive Summary
2.1. Market Snapshot: Global Monkeypox Vaccines And Treatments Market
2.2. Global Monkeypox Vaccines And Treatments Market, By Product, 2022 (US$ Million)
2.3. Global Monkeypox Vaccines And Treatments Market, By Gender, 2022 (US$ Million)
2.4. Global Monkeypox Vaccines And Treatments Market, By Route of Administration, 2022 (US$ Million)
2.5. Global Monkeypox Vaccines And Treatments Market, By End-use, 2022 (US$ Million)
2.6. Global Monkeypox Vaccines And Treatments Market, By Geography, 2022 (US$ Million)
2.7. Attractive Investment Proposition by Geography, 2022
3. Monkeypox Vaccines And Treatments Market: Competitive Analysis
3.1. Market Positioning of Key Monkeypox Vaccines And Treatments Market Vendors
3.2. Strategies Adopted by Monkeypox Vaccines And Treatments Market Vendors
3.3. Key Industry Strategies
3.4. Tier Analysis 2022 Versus 2031
4. Monkeypox Vaccines And Treatments Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Monkeypox Vaccines And Treatments Market Value, 2021 - 2031, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
5. Monkeypox Vaccines And Treatments Market: By Product, 2021-2031, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2022 Versus 2031
5.3. Market Segmentation
5.3.1. Vaccine
5.3.1.1. JYNNEOS/ Imvanex
5.3.1.2. Smallpox Vaccine
5.3.1.3. Others
5.3.2. Drugs
5.3.2.1. Tecovirimat
5.3.2.2. Brincidofovir
5.3.2.3. Cidofovir
5.3.2.4. Others
5.3.3. Vaccinia Immune Globulin (VIG)
6. Monkeypox Vaccines And Treatments Market: By Gender, 2021-2031, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2022 Versus 2031
6.3. Market Segmentation
6.3.1. Male
6.3.2. Female
6.3.3. Others
7. Monkeypox Vaccines And Treatments Market: By Route of Administration, 2021-2031, USD (Million)
7.1. Market Overview
7.2. Growth & Revenue Analysis: 2022 Versus 2031
7.3. Market Segmentation
7.3.1. Oral
7.3.2. Injectable
8. Monkeypox Vaccines And Treatments Market: By End-use, 2021-2031, USD (Million)
8.1. Market Overview
8.2. Growth & Revenue Analysis: 2022 Versus 2031
8.3. Market Segmentation
8.3.1. Hospitals
8.3.2. Specialty Clinics
8.3.3. Others
9. North America Monkeypox Vaccines And Treatments Market, 2021-2031, USD (Million)
9.1. Market Overview
9.2. Monkeypox Vaccines And Treatments Market: By Product, 2021-2031, USD (Million)
9.3. Monkeypox Vaccines And Treatments Market: By Gender, 2021-2031, USD (Million)
9.4. Monkeypox Vaccines And Treatments Market: By Route of Administration, 2021-2031, USD (Million)
9.5. Monkeypox Vaccines And Treatments Market: By End-use, 2021-2031, USD (Million)
9.6.Monkeypox Vaccines And Treatments Market: By Region, 2021-2031, USD (Million)
9.6.1.North America
9.6.1.1. U.S.
9.6.1.1.1. Monkeypox Vaccines And Treatments Market: By Product, 2021-2031, USD (Million)
9.6.1.1.1. Monkeypox Vaccines And Treatments Market: By Gender, 2021-2031, USD (Million)
9.6.1.1.1. Monkeypox Vaccines And Treatments Market: By Route of Administration, 2021-2031, USD (Million)
9.6.1.1.1. Monkeypox Vaccines And Treatments Market: By End-use, 2021-2031, USD (Million)
9.6.1.2. Canada
9.6.1.2.1. Monkeypox Vaccines And Treatments Market: By Product, 2021-2031, USD (Million)
9.6.1.2.1. Monkeypox Vaccines And Treatments Market: By Gender, 2021-2031, USD (Million)
9.6.1.2.1. Monkeypox Vaccines And Treatments Market: By Route of Administration, 2021-2031, USD (Million)
9.6.1.2.1. Monkeypox Vaccines And Treatments Market: By End-use, 2021-2031, USD (Million)
9.6.1.3. Rest of North America
9.6.1.3.1. Monkeypox Vaccines And Treatments Market: By Product, 2021-2031, USD (Million)
9.6.1.3.1. Monkeypox Vaccines And Treatments Market: By Gender, 2021-2031, USD (Million)
9.6.1.3.1. Monkeypox Vaccines And Treatments Market: By Route of Administration, 2021-2031, USD (Million)
9.6.1.3.1. Monkeypox Vaccines And Treatments Market: By End-use, 2021-2031, USD (Million)
10. UK and European Union Monkeypox Vaccines And Treatments Market, 2021-2031, USD (Million)
10.1. Market Overview
10.2. Monkeypox Vaccines And Treatments Market: By Product, 2021-2031, USD (Million)
10.3. Monkeypox Vaccines And Treatments Market: By Gender, 2021-2031, USD (Million)
10.4. Monkeypox Vaccines And Treatments Market: By Route of Administration, 2021-2031, USD (Million)
10.5. Monkeypox Vaccines And Treatments Market: By End-use, 2021-2031, USD (Million)
10.6.Monkeypox Vaccines And Treatments Market: By Region, 2021-2031, USD (Million)
10.6.1.UK and European Union
10.6.1.1. UK
10.6.1.1.1. Monkeypox Vaccines And Treatments Market: By Product, 2021-2031, USD (Million)
10.6.1.1.1. Monkeypox Vaccines And Treatments Market: By Gender, 2021-2031, USD (Million)
10.6.1.1.1. Monkeypox Vaccines And Treatments Market: By Route of Administration, 2021-2031, USD (Million)
10.6.1.1.1. Monkeypox Vaccines And Treatments Market: By End-use, 2021-2031, USD (Million)
10.6.1.2. Germany
10.6.1.2.1. Monkeypox Vaccines And Treatments Market: By Product, 2021-2031, USD (Million)
10.6.1.2.1. Monkeypox Vaccines And Treatments Market: By Gender, 2021-2031, USD (Million)
10.6.1.2.1. Monkeypox Vaccines And Treatments Market: By Route of Administration, 2021-2031, USD (Million)
10.6.1.2.1. Monkeypox Vaccines And Treatments Market: By End-use, 2021-2031, USD (Million)
10.6.1.3. Spain
10.6.1.3.1. Monkeypox Vaccines And Treatments Market: By Product, 2021-2031, USD (Million)
10.6.1.3.1. Monkeypox Vaccines And Treatments Market: By Gender, 2021-2031, USD (Million)
10.6.1.3.1. Monkeypox Vaccines And Treatments Market: By Route of Administration, 2021-2031, USD (Million)
10.6.1.3.1. Monkeypox Vaccines And Treatments Market: By End-use, 2021-2031, USD (Million)
10.6.1.4. Italy
10.6.1.4.1. Monkeypox Vaccines And Treatments Market: By Product, 2021-2031, USD (Million)
10.6.1.4.1. Monkeypox Vaccines And Treatments Market: By Gender, 2021-2031, USD (Million)
10.6.1.4.1. Monkeypox Vaccines And Treatments Market: By Route of Administration, 2021-2031, USD (Million)
10.6.1.4.1. Monkeypox Vaccines And Treatments Market: By End-use, 2021-2031, USD (Million)
10.6.1.5. France
10.6.1.5.1. Monkeypox Vaccines And Treatments Market: By Product, 2021-2031, USD (Million)
10.6.1.5.1. Monkeypox Vaccines And Treatments Market: By Gender, 2021-2031, USD (Million)
10.6.1.5.1. Monkeypox Vaccines And Treatments Market: By Route of Administration, 2021-2031, USD (Million)
10.6.1.5.1. Monkeypox Vaccines And Treatments Market: By End-use, 2021-2031, USD (Million)
10.6.1.6. Rest of Europe
10.6.1.6.1. Monkeypox Vaccines And Treatments Market: By Product, 2021-2031, USD (Million)
10.6.1.6.1. Monkeypox Vaccines And Treatments Market: By Gender, 2021-2031, USD (Million)
10.6.1.6.1. Monkeypox Vaccines And Treatments Market: By Route of Administration, 2021-2031, USD (Million)
10.6.1.6.1. Monkeypox Vaccines And Treatments Market: By End-use, 2021-2031, USD (Million)
11. Asia Pacific Monkeypox Vaccines And Treatments Market, 2021-2031, USD (Million)
11.1. Market Overview
11.2. Monkeypox Vaccines And Treatments Market: By Product, 2021-2031, USD (Million)
11.3. Monkeypox Vaccines And Treatments Market: By Gender, 2021-2031, USD (Million)
11.4. Monkeypox Vaccines And Treatments Market: By Route of Administration, 2021-2031, USD (Million)
11.5. Monkeypox Vaccines And Treatments Market: By End-use, 2021-2031, USD (Million)
11.6.Monkeypox Vaccines And Treatments Market: By Region, 2021-2031, USD (Million)
11.6.1.Asia Pacific
11.6.1.1. China
11.6.1.1.1. Monkeypox Vaccines And Treatments Market: By Product, 2021-2031, USD (Million)
11.6.1.1.1. Monkeypox Vaccines And Treatments Market: By Gender, 2021-2031, USD (Million)
11.6.1.1.1. Monkeypox Vaccines And Treatments Market: By Route of Administration, 2021-2031, USD (Million)
11.6.1.1.1. Monkeypox Vaccines And Treatments Market: By End-use, 2021-2031, USD (Million)
11.6.1.2. Japan
11.6.1.2.1. Monkeypox Vaccines And Treatments Market: By Product, 2021-2031, USD (Million)
11.6.1.2.1. Monkeypox Vaccines And Treatments Market: By Gender, 2021-2031, USD (Million)
11.6.1.2.1. Monkeypox Vaccines And Treatments Market: By Route of Administration, 2021-2031, USD (Million)
11.6.1.2.1. Monkeypox Vaccines And Treatments Market: By End-use, 2021-2031, USD (Million)
11.6.1.3. India
11.6.1.3.1. Monkeypox Vaccines And Treatments Market: By Product, 2021-2031, USD (Million)
11.6.1.3.1. Monkeypox Vaccines And Treatments Market: By Gender, 2021-2031, USD (Million)
11.6.1.3.1. Monkeypox Vaccines And Treatments Market: By Route of Administration, 2021-2031, USD (Million)
11.6.1.3.1. Monkeypox Vaccines And Treatments Market: By End-use, 2021-2031, USD (Million)
11.6.1.4. Australia
11.6.1.4.1. Monkeypox Vaccines And Treatments Market: By Product, 2021-2031, USD (Million)
11.6.1.4.1. Monkeypox Vaccines And Treatments Market: By Gender, 2021-2031, USD (Million)
11.6.1.4.1. Monkeypox Vaccines And Treatments Market: By Route of Administration, 2021-2031, USD (Million)
11.6.1.4.1. Monkeypox Vaccines And Treatments Market: By End-use, 2021-2031, USD (Million)
11.6.1.5. South Korea
11.6.1.5.1. Monkeypox Vaccines And Treatments Market: By Product, 2021-2031, USD (Million)
11.6.1.5.1. Monkeypox Vaccines And Treatments Market: By Gender, 2021-2031, USD (Million)
11.6.1.5.1. Monkeypox Vaccines And Treatments Market: By Route of Administration, 2021-2031, USD (Million)
11.6.1.5.1. Monkeypox Vaccines And Treatments Market: By End-use, 2021-2031, USD (Million)
11.6.1.6. Rest of Asia Pacific
11.6.1.6.1. Monkeypox Vaccines And Treatments Market: By Product, 2021-2031, USD (Million)
11.6.1.6.1. Monkeypox Vaccines And Treatments Market: By Gender, 2021-2031, USD (Million)
11.6.1.6.1. Monkeypox Vaccines And Treatments Market: By Route of Administration, 2021-2031, USD (Million)
11.6.1.6.1. Monkeypox Vaccines And Treatments Market: By End-use, 2021-2031, USD (Million)
12. Latin America Monkeypox Vaccines And Treatments Market, 2021-2031, USD (Million)
12.1. Market Overview
12.2. Monkeypox Vaccines And Treatments Market: By Product, 2021-2031, USD (Million)
12.3. Monkeypox Vaccines And Treatments Market: By Gender, 2021-2031, USD (Million)
12.4. Monkeypox Vaccines And Treatments Market: By Route of Administration, 2021-2031, USD (Million)
12.5. Monkeypox Vaccines And Treatments Market: By End-use, 2021-2031, USD (Million)
12.6.Monkeypox Vaccines And Treatments Market: By Region, 2021-2031, USD (Million)
12.6.1.Latin America
12.6.1.1. Brazil
12.6.1.1.1. Monkeypox Vaccines And Treatments Market: By Product, 2021-2031, USD (Million)
12.6.1.1.1. Monkeypox Vaccines And Treatments Market: By Gender, 2021-2031, USD (Million)
12.6.1.1.1. Monkeypox Vaccines And Treatments Market: By Route of Administration, 2021-2031, USD (Million)
12.6.1.1.1. Monkeypox Vaccines And Treatments Market: By End-use, 2021-2031, USD (Million)
12.6.1.2. Mexico
12.6.1.2.1. Monkeypox Vaccines And Treatments Market: By Product, 2021-2031, USD (Million)
12.6.1.2.1. Monkeypox Vaccines And Treatments Market: By Gender, 2021-2031, USD (Million)
12.6.1.2.1. Monkeypox Vaccines And Treatments Market: By Route of Administration, 2021-2031, USD (Million)
12.6.1.2.1. Monkeypox Vaccines And Treatments Market: By End-use, 2021-2031, USD (Million)
12.6.1.3. Rest of Latin America
12.6.1.3.1. Monkeypox Vaccines And Treatments Market: By Product, 2021-2031, USD (Million)
12.6.1.3.1. Monkeypox Vaccines And Treatments Market: By Gender, 2021-2031, USD (Million)
12.6.1.3.1. Monkeypox Vaccines And Treatments Market: By Route of Administration, 2021-2031, USD (Million)
12.6.1.3.1. Monkeypox Vaccines And Treatments Market: By End-use, 2021-2031, USD (Million)
13. Middle East and Africa Monkeypox Vaccines And Treatments Market, 2021-2031, USD (Million)
13.1. Market Overview
13.2. Monkeypox Vaccines And Treatments Market: By Product, 2021-2031, USD (Million)
13.3. Monkeypox Vaccines And Treatments Market: By Gender, 2021-2031, USD (Million)
13.4. Monkeypox Vaccines And Treatments Market: By Route of Administration, 2021-2031, USD (Million)
13.5. Monkeypox Vaccines And Treatments Market: By End-use, 2021-2031, USD (Million)
13.6.Monkeypox Vaccines And Treatments Market: By Region, 2021-2031, USD (Million)
13.6.1.Middle East and Africa
13.6.1.1. GCC
13.6.1.1.1. Monkeypox Vaccines And Treatments Market: By Product, 2021-2031, USD (Million)
13.6.1.1.1. Monkeypox Vaccines And Treatments Market: By Gender, 2021-2031, USD (Million)
13.6.1.1.1. Monkeypox Vaccines And Treatments Market: By Route of Administration, 2021-2031, USD (Million)
13.6.1.1.1. Monkeypox Vaccines And Treatments Market: By End-use, 2021-2031, USD (Million)
13.6.1.2. Africa
13.6.1.2.1. Monkeypox Vaccines And Treatments Market: By Product, 2021-2031, USD (Million)
13.6.1.2.1. Monkeypox Vaccines And Treatments Market: By Gender, 2021-2031, USD (Million)
13.6.1.2.1. Monkeypox Vaccines And Treatments Market: By Route of Administration, 2021-2031, USD (Million)
13.6.1.2.1. Monkeypox Vaccines And Treatments Market: By End-use, 2021-2031, USD (Million)
13.6.1.3. Rest of Middle East and Africa
13.6.1.3.1. Monkeypox Vaccines And Treatments Market: By Product, 2021-2031, USD (Million)
13.6.1.3.1. Monkeypox Vaccines And Treatments Market: By Gender, 2021-2031, USD (Million)
13.6.1.3.1. Monkeypox Vaccines And Treatments Market: By Route of Administration, 2021-2031, USD (Million)
13.6.1.3.1. Monkeypox Vaccines And Treatments Market: By End-use, 2021-2031, USD (Million)
14. Company Profile
14.1. SIGA Technologies, Inc.
14.1.1. Company Overview
14.1.2. Financial Performance
14.1.3. Product Portfolio
14.1.4. Strategic Initiatives
14.2. Chimerix, Inc.
14.2.1. Company Overview
14.2.2. Financial Performance
14.2.3. Product Portfolio
14.2.4. Strategic Initiatives
14.3. Bavarian Nordic
14.3.1. Company Overview
14.3.2. Financial Performance
14.3.3. Product Portfolio
14.3.4. Strategic Initiatives
14.4. Sanofi SA
14.4.1. Company Overview
14.4.2. Financial Performance
14.4.3. Product Portfolio
14.4.4. Strategic Initiatives
14.5. Emcure Pharma
14.5.1. Company Overview
14.5.2. Financial Performance
14.5.3. Product Portfolio
14.5.4. Strategic Initiatives
14.6. Jinan Jinda Pharmaceutical Chemistry Co., Ltd.
14.6.1. Company Overview
14.6.2. Financial Performance
14.6.3. Product Portfolio
14.6.4. Strategic Initiatives
14.7. Others
14.7.1. Company Overview
14.7.2. Financial Performance
14.7.3. Product Portfolio
14.7.4. Strategic Initiatives
List of Figures
Figure 1 Global Monkeypox Vaccines And Treatments Market: Market Coverage
Figure 2 Research Methodology and Data Sources
Figure 3 Market Size Estimation - Top Down & Bottom-Up Approach
Figure 4 Global Monkeypox Vaccines And Treatments Market: Quality Assurance
Figure 5 Global Monkeypox Vaccines And Treatments Market, By Product, 2022
Figure 6 Global Monkeypox Vaccines And Treatments Market, By Gender, 2022
Figure 7 Global Monkeypox Vaccines And Treatments Market, By Route of Administration, 2022
Figure 8 Global Monkeypox Vaccines And Treatments Market, By End-use, 2022
Figure 9 Global Monkeypox Vaccines And Treatments Market, By Geography, 2022
Figure 10 Market Geographical Opportunity Matrix - Global Monkeypox Vaccines And Treatments Market, 2022
Figure 11 Market Positioning of Key Monkeypox Vaccines And Treatments Market Players, 2022
Figure 12 Global Monkeypox Vaccines And Treatments Market - Tier Analysis - Percentage of Revenues by Tier Level, 2022 Versus 2031
Figure 13 Global Monkeypox Vaccines And Treatments Market, By Product, 2022 Vs 2031, %
Figure 14 Global Monkeypox Vaccines And Treatments Market, By Gender, 2022 Vs 2031, %
Figure 15 Global Monkeypox Vaccines And Treatments Market, By Route of Administration, 2022 Vs 2031, %
Figure 16 Global Monkeypox Vaccines And Treatments Market, By End-use, 2022 Vs 2031, %
Figure 17 U.S. Monkeypox Vaccines And Treatments Market (US$ Million), 2021 - 2031
Figure 18 Canada Monkeypox Vaccines And Treatments Market (US$ Million), 2021 - 2031
Figure 19 Rest of North America Monkeypox Vaccines And Treatments Market (US$ Million), 2021 - 2031
Figure 20 UK Monkeypox Vaccines And Treatments Market (US$ Million), 2021 - 2031
Figure 21 Germany Monkeypox Vaccines And Treatments Market (US$ Million), 2021 - 2031
Figure 22 Spain Monkeypox Vaccines And Treatments Market (US$ Million), 2021 - 2031
Figure 23 Italy Monkeypox Vaccines And Treatments Market (US$ Million), 2021 - 2031
Figure 24 France Monkeypox Vaccines And Treatments Market (US$ Million), 2021 - 2031
Figure 25 Rest of Europe Monkeypox Vaccines And Treatments Market (US$ Million), 2021 - 2031
Figure 26 China Monkeypox Vaccines And Treatments Market (US$ Million), 2021 - 2031
Figure 27 Japan Monkeypox Vaccines And Treatments Market (US$ Million), 2021 - 2031
Figure 28 India Monkeypox Vaccines And Treatments Market (US$ Million), 2021 - 2031
Figure 29 Australia Monkeypox Vaccines And Treatments Market (US$ Million), 2021 - 2031
Figure 30 South Korea Monkeypox Vaccines And Treatments Market (US$ Million), 2021 - 2031
Figure 31 Rest of Asia Monkeypox Vaccines And Treatments Market (US$ Million), 2021 - 2031
Figure 32 Brazil Monkeypox Vaccines And Treatments Market (US$ Million), 2021 - 2031
Figure 33 Mexico Monkeypox Vaccines And Treatments Market (US$ Million), 2021 - 2031
Figure 34 Rest of Latin America Monkeypox Vaccines And Treatments Market (US$ Million), 2021 - 2031
Figure 35 GCC Monkeypox Vaccines And Treatments Market (US$ Million), 2021 - 2031
Figure 36 Africa Monkeypox Vaccines And Treatments Market (US$ Million), 2021 - 2031
Figure 37 Rest of Middle East and Africa Monkeypox Vaccines And Treatments Market (US$ Million), 2021 - 2031
List of Tables
Table 1 Global Monkeypox Vaccines And Treatments Market By Product, 2021-2031, USD (Million)
Table 2 Global Monkeypox Vaccines And Treatments Market By Vaccine, 2021-2031, USD (Million)
Table 3 Global Monkeypox Vaccines And Treatments Market By Drugs, 2021-2031, USD (Million)
Table 4 Global Monkeypox Vaccines And Treatments Market By Gender, 2021-2031, USD (Million)
Table 5 Global Monkeypox Vaccines And Treatments Market By Route of Administration, 2021-2031, USD (Million)
Table 6 Global Monkeypox Vaccines And Treatments Market By End-use, 2021-2031, USD (Million)
Table 7 North America Monkeypox Vaccines And Treatments Market By Product, 2021-2031, USD (Million)
Table 8 North America Monkeypox Vaccines And Treatments Market By Vaccine, 2021-2031, USD (Million)
Table 9 North America Monkeypox Vaccines And Treatments Market By Drugs, 2021-2031, USD (Million)
Table 10 North America Monkeypox Vaccines And Treatments Market By Gender, 2021-2031, USD (Million)
Table 11 North America Monkeypox Vaccines And Treatments Market By Route of Administration, 2021-2031, USD (Million)
Table 12 North America Monkeypox Vaccines And Treatments Market By End-use, 2021-2031, USD (Million)
Table 13 U.S. Monkeypox Vaccines And Treatments Market By Product, 2021-2031, USD (Million)
Table 14 U.S. Monkeypox Vaccines And Treatments Market By Vaccine, 2021-2031, USD (Million)
Table 15 U.S. Monkeypox Vaccines And Treatments Market By Drugs, 2021-2031, USD (Million)
Table 16 U.S. Monkeypox Vaccines And Treatments Market By Gender, 2021-2031, USD (Million)
Table 17 U.S. Monkeypox Vaccines And Treatments Market By Route of Administration, 2021-2031, USD (Million)
Table 18 U.S. Monkeypox Vaccines And Treatments Market By End-use, 2021-2031, USD (Million)
Table 19 Canada Monkeypox Vaccines And Treatments Market By Product, 2021-2031, USD (Million)
Table 20 Canada Monkeypox Vaccines And Treatments Market By Vaccine, 2021-2031, USD (Million)
Table 21 Canada Monkeypox Vaccines And Treatments Market By Drugs, 2021-2031, USD (Million)
Table 22 Canada Monkeypox Vaccines And Treatments Market By Gender, 2021-2031, USD (Million)
Table 23 Canada Monkeypox Vaccines And Treatments Market By Route of Administration, 2021-2031, USD (Million)
Table 24 Canada Monkeypox Vaccines And Treatments Market By End-use, 2021-2031, USD (Million)
Table 25 Rest of North America Monkeypox Vaccines And Treatments Market By Product, 2021-2031, USD (Million)
Table 26 Rest of North America Monkeypox Vaccines And Treatments Market By Vaccine, 2021-2031, USD (Million)
Table 27 Rest of North America Monkeypox Vaccines And Treatments Market By Drugs, 2021-2031, USD (Million)
Table 28 Rest of North America Monkeypox Vaccines And Treatments Market By Gender, 2021-2031, USD (Million)
Table 29 Rest of North America Monkeypox Vaccines And Treatments Market By Route of Administration, 2021-2031, USD (Million)
Table 30 Rest of North America Monkeypox Vaccines And Treatments Market By End-use, 2021-2031, USD (Million)
Table 31 UK and European Union Monkeypox Vaccines And Treatments Market By Product, 2021-2031, USD (Million)
Table 32 UK and European Union Monkeypox Vaccines And Treatments Market By Vaccine, 2021-2031, USD (Million)
Table 33 UK and European Union Monkeypox Vaccines And Treatments Market By Drugs, 2021-2031, USD (Million)
Table 34 UK and European Union Monkeypox Vaccines And Treatments Market By Gender, 2021-2031, USD (Million)
Table 35 UK and European Union Monkeypox Vaccines And Treatments Market By Route of Administration, 2021-2031, USD (Million)
Table 36 UK and European Union Monkeypox Vaccines And Treatments Market By End-use, 2021-2031, USD (Million)
Table 37 UK Monkeypox Vaccines And Treatments Market By Product, 2021-2031, USD (Million)
Table 38 UK Monkeypox Vaccines And Treatments Market By Vaccine, 2021-2031, USD (Million)
Table 39 UK Monkeypox Vaccines And Treatments Market By Drugs, 2021-2031, USD (Million)
Table 40 UK Monkeypox Vaccines And Treatments Market By Gender, 2021-2031, USD (Million)
Table 41 UK Monkeypox Vaccines And Treatments Market By Route of Administration, 2021-2031, USD (Million)
Table 42 UK Monkeypox Vaccines And Treatments Market By End-use, 2021-2031, USD (Million)
Table 43 Germany Monkeypox Vaccines And Treatments Market By Product, 2021-2031, USD (Million)
Table 44 Germany Monkeypox Vaccines And Treatments Market By Vaccine, 2021-2031, USD (Million)
Table 45 Germany Monkeypox Vaccines And Treatments Market By Drugs, 2021-2031, USD (Million)
Table 46 Germany Monkeypox Vaccines And Treatments Market By Gender, 2021-2031, USD (Million)
Table 47 Germany Monkeypox Vaccines And Treatments Market By Route of Administration, 2021-2031, USD (Million)
Table 48 Germany Monkeypox Vaccines And Treatments Market By End-use, 2021-2031, USD (Million)
Table 49 Spain Monkeypox Vaccines And Treatments Market By Product, 2021-2031, USD (Million)
Table 50 Spain Monkeypox Vaccines And Treatments Market By Vaccine, 2021-2031, USD (Million)
Table 51 Spain Monkeypox Vaccines And Treatments Market By Drugs, 2021-2031, USD (Million)
Table 52 Spain Monkeypox Vaccines And Treatments Market By Gender, 2021-2031, USD (Million)
Table 53 Spain Monkeypox Vaccines And Treatments Market By Route of Administration, 2021-2031, USD (Million)
Table 54 Spain Monkeypox Vaccines And Treatments Market By End-use, 2021-2031, USD (Million)
Table 55 Italy Monkeypox Vaccines And Treatments Market By Product, 2021-2031, USD (Million)
Table 56 Italy Monkeypox Vaccines And Treatments Market By Vaccine, 2021-2031, USD (Million)
Table 57 Italy Monkeypox Vaccines And Treatments Market By Drugs, 2021-2031, USD (Million)
Table 58 Italy Monkeypox Vaccines And Treatments Market By Gender, 2021-2031, USD (Million)
Table 59 Italy Monkeypox Vaccines And Treatments Market By Route of Administration, 2021-2031, USD (Million)
Table 60 Italy Monkeypox Vaccines And Treatments Market By End-use, 2021-2031, USD (Million)
Table 61 France Monkeypox Vaccines And Treatments Market By Product, 2021-2031, USD (Million)
Table 62 France Monkeypox Vaccines And Treatments Market By Vaccine, 2021-2031, USD (Million)
Table 63 France Monkeypox Vaccines And Treatments Market By Drugs, 2021-2031, USD (Million)
Table 64 France Monkeypox Vaccines And Treatments Market By Gender, 2021-2031, USD (Million)
Table 65 France Monkeypox Vaccines And Treatments Market By Route of Administration, 2021-2031, USD (Million)
Table 66 France Monkeypox Vaccines And Treatments Market By End-use, 2021-2031, USD (Million)
Table 67 Rest of Europe Monkeypox Vaccines And Treatments Market By Product, 2021-2031, USD (Million)
Table 68 Rest of Europe Monkeypox Vaccines And Treatments Market By Vaccine, 2021-2031, USD (Million)
Table 69 Rest of Europe Monkeypox Vaccines And Treatments Market By Drugs, 2021-2031, USD (Million)
Table 70 Rest of Europe Monkeypox Vaccines And Treatments Market By Gender, 2021-2031, USD (Million)
Table 71 Rest of Europe Monkeypox Vaccines And Treatments Market By Route of Administration, 2021-2031, USD (Million)
Table 72 Rest of Europe Monkeypox Vaccines And Treatments Market By End-use, 2021-2031, USD (Million)
Table 73 Asia Monkeypox Vaccines And Treatments Market By Product, 2021-2031, USD (Million)
Table 74 Asia Monkeypox Vaccines And Treatments Market By Vaccine, 2021-2031, USD (Million)
Table 75 Asia Monkeypox Vaccines And Treatments Market By Drugs, 2021-2031, USD (Million)
Table 76 Asia Monkeypox Vaccines And Treatments Market By Gender, 2021-2031, USD (Million)
Table 77 Asia Monkeypox Vaccines And Treatments Market By Route of Administration, 2021-2031, USD (Million)
Table 78 Asia Monkeypox Vaccines And Treatments Market By End-use, 2021-2031, USD (Million)
Table 79 China Monkeypox Vaccines And Treatments Market By Product, 2021-2031, USD (Million)
Table 80 China Monkeypox Vaccines And Treatments Market By Vaccine, 2021-2031, USD (Million)
Table 81 China Monkeypox Vaccines And Treatments Market By Drugs, 2021-2031, USD (Million)
Table 82 China Monkeypox Vaccines And Treatments Market By Gender, 2021-2031, USD (Million)
Table 83 China Monkeypox Vaccines And Treatments Market By Route of Administration, 2021-2031, USD (Million)
Table 84 China Monkeypox Vaccines And Treatments Market By End-use, 2021-2031, USD (Million)
Table 85 Japan Monkeypox Vaccines And Treatments Market By Product, 2021-2031, USD (Million)
Table 86 Japan Monkeypox Vaccines And Treatments Market By Vaccine, 2021-2031, USD (Million)
Table 87 Japan Monkeypox Vaccines And Treatments Market By Drugs, 2021-2031, USD (Million)
Table 88 Japan Monkeypox Vaccines And Treatments Market By Gender, 2021-2031, USD (Million)
Table 89 Japan Monkeypox Vaccines And Treatments Market By Route of Administration, 2021-2031, USD (Million)
Table 90 Japan Monkeypox Vaccines And Treatments Market By End-use, 2021-2031, USD (Million)
Table 91 India Monkeypox Vaccines And Treatments Market By Product, 2021-2031, USD (Million)
Table 92 India Monkeypox Vaccines And Treatments Market By Vaccine, 2021-2031, USD (Million)
Table 93 India Monkeypox Vaccines And Treatments Market By Drugs, 2021-2031, USD (Million)
Table 94 India Monkeypox Vaccines And Treatments Market By Gender, 2021-2031, USD (Million)
Table 95 India Monkeypox Vaccines And Treatments Market By Route of Administration, 2021-2031, USD (Million)
Table 96 India Monkeypox Vaccines And Treatments Market By End-use, 2021-2031, USD (Million)
Table 97 Australia Monkeypox Vaccines And Treatments Market By Product, 2021-2031, USD (Million)
Table 98 Australia Monkeypox Vaccines And Treatments Market By Vaccine, 2021-2031, USD (Million)
Table 99 Australia Monkeypox Vaccines And Treatments Market By Drugs, 2021-2031, USD (Million)
Table 100 Australia Monkeypox Vaccines And Treatments Market By Gender, 2021-2031, USD (Million)
Table 101 Australia Monkeypox Vaccines And Treatments Market By Route of Administration, 2021-2031, USD (Million)
Table 102 Australia Monkeypox Vaccines And Treatments Market By End-use, 2021-2031, USD (Million)
Table 103 South Korea Monkeypox Vaccines And Treatments Market By Product, 2021-2031, USD (Million)
Table 104 South Korea Monkeypox Vaccines And Treatments Market By Vaccine, 2021-2031, USD (Million)
Table 105 South Korea Monkeypox Vaccines And Treatments Market By Drugs, 2021-2031, USD (Million)
Table 106 South Korea Monkeypox Vaccines And Treatments Market By Gender, 2021-2031, USD (Million)
Table 107 South Korea Monkeypox Vaccines And Treatments Market By Route of Administration, 2021-2031, USD (Million)
Table 108 South Korea Monkeypox Vaccines And Treatments Market By End-use, 2021-2031, USD (Million)
Table 109 Latin America Monkeypox Vaccines And Treatments Market By Product, 2021-2031, USD (Million)
Table 110 Latin America Monkeypox Vaccines And Treatments Market By Vaccine, 2021-2031, USD (Million)
Table 111 Latin America Monkeypox Vaccines And Treatments Market By Drugs, 2021-2031, USD (Million)
Table 112 Latin America Monkeypox Vaccines And Treatments Market By Gender, 2021-2031, USD (Million)
Table 113 Latin America Monkeypox Vaccines And Treatments Market By Route of Administration, 2021-2031, USD (Million)
Table 114 Latin America Monkeypox Vaccines And Treatments Market By End-use, 2021-2031, USD (Million)
Table 115 Brazil Monkeypox Vaccines And Treatments Market By Product, 2021-2031, USD (Million)
Table 116 Brazil Monkeypox Vaccines And Treatments Market By Vaccine, 2021-2031, USD (Million)
Table 117 Brazil Monkeypox Vaccines And Treatments Market By Drugs, 2021-2031, USD (Million)
Table 118 Brazil Monkeypox Vaccines And Treatments Market By Gender, 2021-2031, USD (Million)
Table 119 Brazil Monkeypox Vaccines And Treatments Market By Route of Administration, 2021-2031, USD (Million)
Table 120 Brazil Monkeypox Vaccines And Treatments Market By End-use, 2021-2031, USD (Million)
Table 121 Mexico Monkeypox Vaccines And Treatments Market By Product, 2021-2031, USD (Million)
Table 122 Mexico Monkeypox Vaccines And Treatments Market By Vaccine, 2021-2031, USD (Million)
Table 123 Mexico Monkeypox Vaccines And Treatments Market By Drugs, 2021-2031, USD (Million)
Table 124 Mexico Monkeypox Vaccines And Treatments Market By Gender, 2021-2031, USD (Million)
Table 125 Mexico Monkeypox Vaccines And Treatments Market By Route of Administration, 2021-2031, USD (Million)
Table 126 Mexico Monkeypox Vaccines And Treatments Market By End-use, 2021-2031, USD (Million)
Table 127 Rest of Latin America Monkeypox Vaccines And Treatments Market By Product, 2021-2031, USD (Million)
Table 128 Rest of Latin America Monkeypox Vaccines And Treatments Market By Vaccine, 2021-2031, USD (Million)
Table 129 Rest of Latin America Monkeypox Vaccines And Treatments Market By Drugs, 2021-2031, USD (Million)
Table 130 Rest of Latin America Monkeypox Vaccines And Treatments Market By Gender, 2021-2031, USD (Million)
Table 131 Rest of Latin America Monkeypox Vaccines And Treatments Market By Route of Administration, 2021-2031, USD (Million)
Table 132 Rest of Latin America Monkeypox Vaccines And Treatments Market By End-use, 2021-2031, USD (Million)
Table 133 Middle East and Africa Monkeypox Vaccines And Treatments Market By Product, 2021-2031, USD (Million)
Table 134 Middle East and Africa Monkeypox Vaccines And Treatments Market By Vaccine, 2021-2031, USD (Million)
Table 135 Middle East and Africa Monkeypox Vaccines And Treatments Market By Drugs, 2021-2031, USD (Million)
Table 136 Middle East and Africa Monkeypox Vaccines And Treatments Market By Gender, 2021-2031, USD (Million)
Table 137 Middle East and Africa Monkeypox Vaccines And Treatments Market By Route of Administration, 2021-2031, USD (Million)
Table 138 Middle East and Africa Monkeypox Vaccines And Treatments Market By End-use, 2021-2031, USD (Million)
Table 139 GCC Monkeypox Vaccines And Treatments Market By Product, 2021-2031, USD (Million)
Table 140 GCC Monkeypox Vaccines And Treatments Market By Vaccine, 2021-2031, USD (Million)
Table 141 GCC Monkeypox Vaccines And Treatments Market By Drugs, 2021-2031, USD (Million)
Table 142 GCC Monkeypox Vaccines And Treatments Market By Gender, 2021-2031, USD (Million)
Table 143 GCC Monkeypox Vaccines And Treatments Market By Route of Administration, 2021-2031, USD (Million)
Table 144 GCC Monkeypox Vaccines And Treatments Market By End-use, 2021-2031, USD (Million)
Table 145 Africa Monkeypox Vaccines And Treatments Market By Product, 2021-2031, USD (Million)
Table 146 Africa Monkeypox Vaccines And Treatments Market By Vaccine, 2021-2031, USD (Million)
Table 147 Africa Monkeypox Vaccines And Treatments Market By Drugs, 2021-2031, USD (Million)
Table 148 Africa Monkeypox Vaccines And Treatments Market By Gender, 2021-2031, USD (Million)
Table 149 Africa Monkeypox Vaccines And Treatments Market By Route of Administration, 2021-2031, USD (Million)
Table 150 Africa Monkeypox Vaccines And Treatments Market By End-use, 2021-2031, USD (Million)
Table 151 Rest of Middle East and Africa Monkeypox Vaccines And Treatments Market By Product, 2021-2031, USD (Million)
Table 152 Rest of Middle East and Africa Monkeypox Vaccines And Treatments Market By Vaccine, 2021-2031, USD (Million)
Table 153 Rest of Middle East and Africa Monkeypox Vaccines And Treatments Market By Drugs, 2021-2031, USD (Million)
Table 154 Rest of Middle East and Africa Monkeypox Vaccines And Treatments Market By Gender, 2021-2031, USD (Million)
Table 155 Rest of Middle East and Africa Monkeypox Vaccines And Treatments Market By Route of Administration, 2021-2031, USD (Million)
Table 156 Rest of Middle East and Africa Monkeypox Vaccines And Treatments Market By End-use, 2021-2031, USD (Million)
Companies Mentioned
- SIGA Technologies Inc.
- Chimerix Inc.
- Bavarian Nordic
- Sanofi SA
- Emcure Pharma
- Jinan Jinda Pharmaceutical Chemistry Co. Ltd.
![Vaccine Market: Trends, Opportunities and Competitive Analysis [2024-2030] - Product Image](http://www.researchandmarkets.com/product_images/12459/12459681_60px_jpg/vaccine_market.jpg)
